LEADER 02117oam  2200589   450 
001 9910709770603321
005 20230109094321.0
035   $a(CKB)5470000002472538
035   $a(OCoLC)1041706883
035   $a(EXLCZ)995470000002472538
100   $a20180622d2018      ua             0
101 0 $aeng
135   $aurbn||||a||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 10$aMedicaid Drug Review, Utilization, Good Governance Improvement Act $ereport (to accompany H.R. 5799) (including cost estimate of the Congressional Budget Office)
210  1$a[Washington, D.C.] :$c[U.S. Government Publishing Office],$d[2018]
215   $a1 online resource (147 pages)
225 1 $aReport / 115th Congress, 2d session, House of Representatives ;$v115-728
300   $a"June 12, 2018."
320   $aIncludes bibliographical references.
517   $aMedicaid Drug Review, Utilization, Good Governance Improvement Act 
606   $aMedicare beneficiaries$xIdentification
606   $aDrugs$zUnited States$xSafety measures
606   $aMedicare fraud$xPrevention
606   $aMedicaid fraud$xPrevention
606   $aFraud$xPrevention$xGovernment policy$zUnited States
606   $aOpioid abuse$xTreatment$zUnited States$xCosts
606   $aMedicare$xCost control
606   $aMedicare$xLaw and legislation
608   $aLegislative materials.$2lcgft
615  0$aMedicare beneficiaries$xIdentification.
615  0$aDrugs$xSafety measures.
615  0$aMedicare fraud$xPrevention.
615  0$aMedicaid fraud$xPrevention.
615  0$aFraud$xPrevention$xGovernment policy
615  0$aOpioid abuse$xTreatment$xCosts.
615  0$aMedicare$xCost control.
615  0$aMedicare$xLaw and legislation.
801  0$bGPO
801  1$bGPO
801  2$bGPO
801  2$bIUL
801  2$bMERUC
801  2$bOCLCF
801  2$bINT
801  2$bGPO
906   $aBOOK
912   $a9910709770603321
996   $aMedicaid Drug Review, Utilization, Good Governance Improvement Act$93526786
997   $aUNINA